It is well established that critically ill patients have a deficiency of the amino acid glutamine. This article reviews the evidence for supplemental glutamine in the critically ill, focusing on the benefits in terms of reduced mortality and infectious morbidity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.12968/hosp.2002.63.3.2058 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!